We are live on ! Find out more
BEAT

BioTelemetry, Inc.
BEAT

Delisted

BEAT was delisted on the 8th of February, 2021.

75 hedge funds and large institutions have $176M invested in BioTelemetry, Inc. in 2013 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 11

100% more capital invested

Capital invested by funds: $87.7M → $176M (+$88.1M)

95% more call options, than puts

Call options by funds: $4.7M | Put options by funds: $2.41M

32% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 19

23% more funds holding

Funds holding: 6175 (+14)

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
75
Holders Change
+14
Holders Change %
+22.95%
% of All Funds
2.42%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
25
Increased
25
Reduced
19
Closed
11
Calls
$4.7M
Puts
$2.41M
Net Calls
+$2.28M
Net Calls Change
+$1.87M

BEAT Hedge Fund Activity: Q3 2013 in Review

75 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q3 2013, worth a combined $176M — up 100% from $87.7M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new BEAT positions and 11 closed out — a net gain of 14 holders — while 25 added to existing stakes and 19 trimmed.

The largest buyer was Columbia Partners Investment Management, adding an estimated $12.6M. The largest seller was Camber Capital Management, exiting entirely with an estimated $10.6M sold.

  • 75 institutional investors held BioTelemetry, Inc. (BEAT) as of Q3 2013, up from 61 in Q2 2013.
  • Funds reported $176M of BioTelemetry, Inc. stock for Q3 2013, up 100% quarter-over-quarter.
  • 25 funds opened new BioTelemetry, Inc. positions in Q3 2013 and 11 closed out, a net change of +14 holders.
  • The largest BioTelemetry, Inc. buyer in Q3 2013 was Columbia Partners Investment Management, an estimated $12.6M added.
  • The largest BioTelemetry, Inc. seller in Q3 2013 was Camber Capital Management, an estimated $10.6M sold.

Based on aggregated 13F filings for Q3 2013.